Curated News
By: NewsRamp Editorial Staff
September 29, 2026
Earth Science Tech Expands Pharmacy Network with Meduvo Acquisition
TLDR
- Earth Science Tech acquires Meduvo, expanding to 34 U.S. jurisdictions and gaining a West Coast hub to strengthen its compounding pharmacy network.
- The acquisition integrates Meduvo's 2,000-square-foot facility into ETST's network, with plans for sterile-compounding upgrades and certification by 2028.
- This acquisition enhances patient access to compounded medications through improved telemedicine and pharmacy fulfillment across more U.S. regions.
- Meduvo LLC, a California compounding pharmacy, is now part of Earth Science Tech's growing healthcare platform spanning 34 U.S. jurisdictions.
Impact - Why it Matters
This acquisition matters because it significantly expands Earth Science Tech's operational footprint in the compounding pharmacy and telemedicine sectors. By adding Meduvo's California facility, ETST gains a West Coast hub, enhancing its ability to serve patients across 34 U.S. jurisdictions. The planned upgrade to sterile-compounding capabilities, with certification targeted by 2028, positions the company to offer higher-acuity medications and compete more effectively in the growing telemedicine and personalized medicine markets. For investors, this move demonstrates ETST's commitment to vertical integration and geographic expansion, potentially driving revenue growth and operational efficiencies. As healthcare increasingly shifts toward remote consultations and customized treatments, ETST's integrated platform could capture significant market share, making this acquisition a strategic step toward long-term value creation.
Summary
Earth Science Tech (OTC: ETST) has acquired Meduvo LLC, a California-based compounding pharmacy in La Verne, expanding its pharmacy network to 34 U.S. jurisdictions and establishing a West Coast operational hub. This strategic move complements ETST's existing compounding pharmacy subsidiaries, RxCompoundStore.com and Mister Meds, and aligns with its goal of building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment.
The company plans to upgrade Meduvo's 2,000-square-foot facility to meet sterile-compounding requirements, targeting regulatory certification by the end of 2028. This acquisition fits ETST's broader strategy of expanding geographic reach, integrating telemedicine with pharmacy fulfillment, and improving operational efficiency. By enhancing its infrastructure, ETST aims to provide seamless patient care from consultation to fulfillment, supported by its real estate investments and consumer products business.
For investors, the latest updates are available in the company's newsroom at https://nnw.fm/ETST. The announcement was distributed by NetworkNewsWire, a specialized communications platform within the Dynamic Brand Portfolio @ IBN. NetworkNewsWire provides financial news and content distribution, leveraging a vast network to reach diverse audiences. This acquisition marks a significant step for ETST in strengthening its healthcare footprint and operational capabilities.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Earth Science Tech Expands Pharmacy Network with Meduvo Acquisition
